Atlas Trials

Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma

Clinical trial NCT02251314 · COMPLETED

Trial details

NCT number
NCT02251314
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Melanoma
Start date
2014-09-01
Primary completion
2015-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.